![]() |
![]() ![]() |
![]() |
Buy Request | ![]() | Sell Offer | ![]() | Company | ![]() | Reviews | ![]() |
Expire | Country | Pic | Subject | Popularity |
never | ![]() | ![]() | Human Papillomavirus (HPV) Virus-Like Particles (VLPs) | 148 |
never | ![]() | ![]() | Hepatitis B Virus (HBV) Virus-Like Particles (VLPs) | 148 |
never | ![]() | ![]() | Virus-Like Particles (VLPs) for Delivery System | 148 |
never | ![]() | ![]() | Virus-Like Particles (VLPs) Production in Plant System | 148 |
never | ![]() | ![]() | Virus-Like Particles (VLPs) Production in E. coli System | 148 |
never | ![]() | ![]() | β-hydroxybutyrylation-Specific Antibody Production Services | 148 |
never | ![]() | ![]() | 2-hydroxyisobutyrylation-Specific Antibody Production Services | 148 |
never | ![]() | ![]() | Butyrylation-Specific Antibody Production Services | 148 |
never | ![]() | ![]() | ScFv Library Construction Protocol | 148 |
never | ![]() | ![]() | Anti-CTLA4 (Ticilimumab)-SPDB-DM4 ADC | 148 |
Copyright © toextrade Inc. All rights reserved. Contact us |